[{"data":1,"prerenderedAt":92},["ShallowReactive",2],{"drug-memantine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":44,"contraindications":68,"warnings":78,"renal":79,"monitoring":80,"interactions":81,"review":82,"examples":85},"memantine",1,{"fa":7,"en":8},"ممانتین","Memantine","neurology",{"fa":11,"en":12},"آنتاگونیست NMDA","NMDA antagonist",[14],{"name":15,"market":16},"Namenda","US",[18,19,7,20],"namenda","نامندا","آلزایمر",[22,36],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-5","tablet","oral","5 mg tablet",{"amount":28,"unit":29,"perUnit":24,"scored":30},5,"mg",false,[16],[33],{"source":34,"section":35},"fda-memantine","3",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-10","10 mg tablet",{"amount":40,"unit":29,"perUnit":24,"scored":30},10,[16],[43],{"source":34,"section":35},[45],{"id":46,"disease":47,"label":48,"population":51,"type":55,"unit":29,"dose":56,"refs":58,"notes":61},"ad","alzheimers",{"fa":49,"en":50},"آلزایمر متوسط تا شدید — دوز هدف ۱۰ mg دو بار (پس از تیتراسیون)","Moderate–severe Alzheimer’s — target 10 mg twice daily (after titration)",{"minAge":52},{"value":53,"unit":54},18,"year","fixed",{"perDose":40,"dosesPerDay":57},2,[59],{"source":34,"section":60},"2",[62],{"text":63,"refs":66},{"fa":64,"en":65},"شروع ۵ mg یک بار؛ افزایش ۵ mg (حداقل یک هفته فاصله): ۱۰ mg\u002Fday (۵ دو بار)، ۱۵ (۵ و ۱۰)، ۲۰ (۱۰ دو بار).","Start 5 mg once daily; increase in 5 mg steps at least 1 week apart: 10 mg\u002Fday (5 twice), 15 (5 + 10), 20 (10 twice).",[67],{"source":34,"section":60},[69],{"id":70,"severity":71,"text":72,"refs":75},"ci","block",{"fa":73,"en":74},"حساسیت به ممانتین.","Hypersensitivity to memantine.",[76],{"source":34,"section":77},"4",[],[],[],[],{"status":83,"reviewer":84,"date":84},"unverified",null,[86],{"regimen":46,"formulation":37,"input":87,"expect":90},{"ageYears":88,"weightKg":89},75,65,{"perDose":40,"perDay":91},20,1792078537713]